CELSION CORP. (CLN was CELN) UP $.33 TO $.59 ON HUGE NEWS Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : CELSION CORP. (CLN was CELN) UP $.33 TO $.59 ON HUGE NEWS

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Dave Gore who wrote (251)	1/31/1999 5:51:00 PM
From: Tech Master	of 518

1) Look here for CELN's capital structure and profile: biz.yahoo.com 2) Insider buying recently: biz.yahoo.com Recent sellers were outsiders (October) the rest are management and directors buying. 3) Recent financing was all Rule 144 common stock under a 506 filing. There are no floorless convertible deals or any of that garbage... Volk is way too smart for that kind of nonsense. Other director info from CELN web site: We have appointed Dr. Max Link former Chairman of (1) Sandoz Pharma AG, (from 1991 to 1993) and (2) Corange Ltd., (1993-1994) as a new director. Corange was recently purchased by Hoffman-LaRoche for $11.5 billion. At present, Dr. Link serves on the Boards of Human Genome Sciences, Alexion Pharmaceuticals, Cell Therapeutics, Access Pharmaceuticals, Protein Design Laboratories and Osiris Therapeutics. His world-wide breadth of experience in bio-technology will be invaluable as we expand into targeted drug delivery and gene therapy. We have also appointed Walter Herbst, Chairman and principal of Herbst LaZar Bell, a designing and engineering company in Chicago, as a new director of the company.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next